MARKET WIRE NEWS

Jazz, Zymeworks' Ziihera trial shows significant PFS improvement, shares rally

Source: SeekingAlpha

2025-11-17 07:13:52 ET

More on Jazz Pharmaceuticals, Zymeworks, etc.

Read the full article on Seeking Alpha

For further details see:

Jazz, Zymeworks’ Ziihera trial shows significant PFS improvement, shares rally
BeiGene

NASDAQ: BEIGF

BEIGF Trading

0.0% G/L:

$23.75 Last:

100 Volume:

$23.75 Open:

mwn-app Ad 300

BEIGF Latest News

BEIGF Stock Data

$38,603,023,416
747,457,849
N/A
299
N/A
Biotechnology & Life Sciences
Healthcare
CH
Basel

Subscribe to Our Newsletter

Link Market Wire News to Your X Account

Download The Market Wire News App